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Abstract
A fluorous tagging strategy coupled with enzymatic synthesis is introduced to efficiently
synthesize multiple phosphatidylinositides, which are then directly immobilized on a fluorous
polytetrafluoroethylene (PTFE) membrane to probe protein-lipid interactions.
Phosphatidylinositol (PtdIns) is a membrane-bound lipid that features a hydrophilic inositol
head unit linked with a hydrophobic diacylglycerol (DAG) through a phosphate group.[1]
Three of the five hydroxyls in inositol undergo dynamic phosphorylation/dephosphorylation
processes to generate the seven known phosphatidylinositides (PIs). Due to their interactions
with a wide range of effector proteins,[2] PIs are one family of the most versatile signaling
molecules that regulate many cellular processes such as cell proliferation and vesicle
transport.[3] Abnormal levels of PIs have been associated with multiple diseases including
cancer and neurodegenerative diseases.[4] However, the detailed mechanisms by which PIs
regulate different diseases are largely unknown, partly because of the difficulty in generating
PI derivatives as cellular probes.
PIs and their derivatives are notorious for their structural complexity, with seven stereogenic
centers and the hydroxyl groups around the inositol head unit having similar reactivity. Most
of the synthetic strategies require selective protection and deprotection of the hydroxyl
groups, and usually take more than 15 steps to synthesize one PI.[5] The synthetic efforts are
daunting when multiple PIs are targeted. In addition, PIs contain both the highly hydrophilic
inositol phosphate head group and highly hydrophobic aliphatic side chains, making them
difficult to purify from the reaction mixtures. Despite elegant work from several groups on
developing novel methods and convergent strategies to prepare PIs and their derivatives,[5]
efficient synthesis of various PIs remains a technical challenge.
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Using enzymes as catalysts in organic synthesis has long been an alternative method to
traditional organic synthesis.[6] This approach has not been extended to PI synthesis
although multiple enzymes that catalyze the formation of various PIs from PtdIns are well
studied.[7] The highly hydrophilic nature of the inositol phosphates head group further
makes it difficult to separate the PIs from the enzymatic reaction mixtures containing
inorganic salts. Utilizing highly fluorinated (fluorous) tags to assist separation of enzymatic
products from mixtures over fluorous media[8] has also been explored. For example, kinetic
resolution of a fluorous ester has been carried out in a fluorous triphasic separative reaction
to generate pure products without chromatography.[9] Recently, fluorous tagged
oligosaccharides have been used as enzymatic substrates in Nimzyme assays to detect
enzymatic activities in cell lysates.[10] However, these developments are focused on one-
step enzymatic transformation and further applications of the products are not explored. We
introduce here “fluorous enzymatic synthesis” (Fig. 1) where tandem enzymatic reactions
are used to generate multiple probes after purification through fluorous solid phase
extraction (FSPE)[8a]. These probes can then be used as enzyme reporters, or be directly
immobilized on a fluorous surface to form a microarray[11] to investigate protein-small
molecule interactions. PtdIns(4,5)P2 is the most well-studied PI and functions as a substrate
of multiple enzymes including phosphoinositide 3-kinase (PI3K) and phospholipase C
(PLC).[12] To validate “fluorous enzymatic synthesis”, we designed the fluorous
PtdIns(4,5)P2 derivative 1 with the fluorous tag at the sn-2 position. The long alkyl chain
was used to ensure similar hydrophobicity and membrane localization as endogenous
PtdIns(4,5)P2 and to minimize the effect of the fluorous group on the head unit, where most
metabolic reactions take place. The fluorophore was also added at the sn-1 position for
sensitive monitoring of subsequent reactions. To synthesize 1 (Scheme 1), the fluorinated
acid 2 was generated by the radical addition of the according perfluorinated iodide C6F13I
with undec-10-enoic acid followed by reduction with lithium aluminum hydride.[13]
Coupling of 2 with the alcohol 3 and subsequent removal of the p-methoxybenzyl (PMB)
protective group provided 4 in 90% yield. The alcohol in 4 was then phosphorylated and
coupled with the inositol head group 5,[5a] and the resulting intermediate was oxidized with
t-BuOOH to generate 6. Next, both benzyloxycarbonyl (Cbz) and benzyl (Bn) groups were
removed by hydrogenolysis while the methoxymethyl (MOM) group was removed by
treatment with trimethylsilyl bromide (TMSBr) followed by methanolysis. The fully
deprotected 7 was produced in 81% yield. Selective coupling of the terminal amine in 7 with
N-hydroxysuccinimide (NHS) ester of fluorescein 8 provided the fluorous, fluorescent
PtdIns(4,5)P2 derivative 1. The critical micelle concentration (CMC) of 1 was measured as
17 μM (Fig. S1), similar to that of the endogenous PtdIns(4,5)P2 suggesting that the fluorous
1 is a good mimic as the endogenous PtdIns(4,5)P2.[14]
To investigate whether the tagged PtdIns(4,5)P2 derivative worked as the enzyme substrate,
the fluorous 1 was treated with purified PI3K, a kinase that phosphorylates endogenous
PtdIns(4,5)P2 to form the corresponding PtdIns(3,4,5)P3 under standard PI3K reaction
conditions.[7a] The reactions were monitored by fluorescent detection of both PtdIns(4,5)P2
and PtdIns(3,4,5)P3 on TLC (Fig. 2). The starting material was cleanly converted to the
product in 6 h under standard assay conditions. Likewise, when treated with PLC, another
metabolic enzyme that utilizes PtdIns(4,5)P2 as a substrate, fluorous 1 was completely
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converted to the product DAG without any indication of formation of side products (Fig. 2).
In cellular systems, PIs work as both starting materials for and products of multiple
enzymatic reactions. To demonstrate that such complexity can also be recapitulated in the
fluorous enzymatic synthesis, the tandem sequence of enzymatic reactions were
investigated. The fluorous PtdIns(3,4,5)P3 generated from the PI3K reaction followed by
FSPE was directly used in a reaction catalyzed by phosphatidylinositol 3,4,5-triphosphate 5-
phosphatase 2 (SHIP2)[7c] to produce the corresponding PtdIns(3,4)P2. As measured by
TLC, the reaction generated a single product within 6 h. After FSPE, the fluorous
PtdIns(3,4)P2 was further subjected to dephosphorylation by phosphatase and tensin
homolog (PTEN)[7d] to yield the corresponding PtdIns(4)P. Again, only the desired product
was produced which was further purified through FSPE (Fig. 2).
Both 31P NMR (Fig. 3) and MS (Fig. S2) were used to demonstrate the efficiency of FSPE
purification. As described above, fluorous PtdIns(4,5)P2 was first treated with PI3K and the
resulting product was used as the substrate in SHIP2 reaction. To purify a product through
FSPE, the reaction mixture was added to a column packed with fluorous silica. The column
was first eluted with 20% and then 60% MeOH in water. As shown in Figure 3, the 31P
NMR of the reaction mixture is dominated by ATP, the phosphate donor for the
phosphorylation, and its hydrolyzed product ADP, with little signal for the PtdIns(3,4,5)P3
product before FSPE. In contrast, after FSPE, the 60% MeOH fraction gave only resonances
corresponding to PtdIns(3,4,5)P3. These results suggest that FSPE efficiently enriches the
desired fluorous product. Such enrichment is also critical for the MS analysis. No molecular
ion was detected for PtdIns(3,4,5)P3 before FSPE while the major signal in the MS spectrum
after FSPE was the enzymatic product PtdIns(3,4,5)P3 (Fig. S2). A similar phenomenon was
observed for the SHIP2 reaction: in both 31P NMR or MS spectra, the desired reaction
product was only detected after FSPE (Fig. 3 and Fig. S2).
Although cleavable linkers can be envisioned to avoid the trace of the fluorous tag on the
enzymatic products, we chose to use non-cleavable fluorous tag for this work so that the
enzymatic products could be directly immobilized on a fluorous surface for a small molecule
array. We chose to use Teflon as the fluorous surface because the fluorous array used in the
literature[11] is no longer commercially available. Equal molar amounts of the three fluorous
tagged PIs, PtdIns(4,5)P2, PtdIns(3,4,5)P3, and PtdIns(3,4)P2, from the enzymatic reactions
were spotted on a perfluorinated Teflon membrane for immobilization. Because each PI
contains the same fluorophore fluorescein, the efficiency of loading was quantified by
fluorescence scanning at the excitation/emission wavelengths of 488/520 nm (Fig. 4A).
Indeed, the intensities of the three lipids were in the same range suggesting that they have
similar capacity to immobilize on the Teflon membrane. When the quantity of the
immobilized lipid doubles, so does the fluorescence intensity. The membrane was then
incubated with biotin-conjugated antibody against PtdIns(3,4,5)P3. After washing with
buffer, the membrane was treated with Cy5-streptavidin and scanned for Cy5 signal
(λex/λem = 633/670 nm) after washing with buffer (Fig. 4B). Only fluorous PtdIns(3,4,5)P3
was detected by anti-PtdIns(3,4,5)P3. Similarly, both fluorous PtdIns(4,5)P2 and
PtdIns(3,4,5)P3 were detected by anti-PtdIns(4,5)P2 (Fig. 4C) while anti-PtdIns(3,4)P2
recognized fluorous PtdIns(3,4)P2 and PtdIns(4,5)P2 (Fig. 4D). These binding profiles are
consistent with the intrinsic affinity of each antibody with different endogenous PIs,[15]
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suggesting that the fluorous tag does not significantly interfere with the antibody-lipid
interactions.
Conclusions
In conclusion, a fluorous enzymatic synthesis strategy was developed to make multiple PIs
which can be directly immobilized onto a fluorous microarray. Our experiments clearly
demonstrate the advantage of the combination of fluorous tagging and enzymatic reactions
in making multiple PIs at both the synthesis and the separation stages. Although cleavable
linkers can be readily incorporated to remove the fluorous tag at the end of the enzymatic
syntheses, this work purposely leaves the tag intact after enzymatic reactions so that the
products could be directly immobilized onto a fluorous microarray. Indeed, the antibodies
against PIs selectively recognize the fluorous-tagged lipids with the same binding profiles as
their non-tagged parents, suggesting that the fluorous tag has little impact on their functions.
This strategy should also be applicable to other complex endogenous small molecules whose
biosynthetic enzymes are well characterized.
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Schematic illustration of “Fluorous Enzymatic Synthesis”. The enzymatic products can be directly immobilized on a fluorous
surface.
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Enzymatic synthesis with PI3K, PLC, SHIP2, and PTEN. The reaction progression was monitored by TLC.
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Efficiency of FSPE on product purification and characterization with 31P NMR.
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Selective binding profiles of fluorous lipids with antibodies on a fluorous membrane.
Huang et al. Page 9























Synthesis of the fluorous substrate PtdIns(4,5)P2.
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